Pharma Deko Cash Flow Statement

Financials in millions NGN. Fiscal year is January - December.

Millions NGN. Fiscal year is Jan - Dec.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Net Income	-296.19	-69.79	-325.21	-278.88	-265.26
Depreciation & Amortization	69.01	67.88	70.93	79.26	75.83
Other Amortization	-	-	-	-	0.24
Loss (Gain) From Sale of Assets	-	0.02	-	-	-
Provision & Write-off of Bad Debts	55.53	-	-	-	-
Other Operating Activities	-0.31	-2.3	-27.43	61.56	80.83
Change in Accounts Receivable	-80.89	8.74	95.97	53.12	-37.76
Change in Inventory	30.6	-8.28	119.23	-38.11	-26.45
Change in Accounts Payable	185.56	-47.27	-17.81	-27.25	-14.76
Change in Other Net Operating Assets	7.99	7.52	188.91	153.01	137.34
Operating Cash Flow	-28.69	-43.48	104.59	2.71	-49.98
Operating Cash Flow Growth	-	-	3758.06%	-	-
Capital Expenditures	-4.66	-26.07	-0.71	-	-14.46
Sale of Property, Plant & Equipment	-	0.23	-	-	-
Investing Cash Flow	-4.66	-25.84	-0.71	-	-14.46
Short-Term Debt Issued	3.78	-	-	-	50
Total Debt Issued	3.78	-	-	-	50
Short-Term Debt Repaid	-	-0.34	-1.66	-35	-
Total Debt Repaid	-	-0.34	-1.66	-35	-
Net Debt Issued (Repaid)	3.78	-0.34	-1.66	-35	50
Common Dividends Paid	-	-	-	-	-10.84
Financing Cash Flow	3.78	-0.34	-1.66	-35	39.16
Foreign Exchange Rate Adjustments	0.61	-	0.03	0.76	0.01
Net Cash Flow	-28.97	-69.65	102.25	-31.53	-25.27
Free Cash Flow	-33.36	-69.54	103.88	2.71	-64.44
Free Cash Flow Growth	-	-	3731.76%	-	-
Free Cash Flow Margin	-7.10%	-13.81%	22.54%	0.56%	-6.29%
Free Cash Flow Per Share	-0.15	-0.32	0.48	0.01	-0.30
Cash Interest Paid	8.93	2.83	2.21	7.45	0.94
Cash Income Tax Paid	1.03	1.16	-	-	1.61
Levered Free Cash Flow	69.4	-76.25	453.4	-6.52	-32.53
Unlevered Free Cash Flow	74.97	-74.48	454.78	-1.86	-31.94
Change in Working Capital	143.26	-39.29	386.3	140.78	58.38

Updated Feb 9, 2023. Source: S&P Global Market Intelligence. Standard template. Financial Sources.